Bottom line
Is SCVAX a good fund? The bottom line
SCVAX is the Class A share class of Allspring Small Company Value Fund, an actively managed small-cap mutual fund from Allspring.
Annual fees run 1.15% — about $115 a year on every $10,000 invested, more expensive than 66% of small-cap funds we track.
It returned −4.1% over one year, +7.5% a year over five years, +8.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $596 million in net assets and 1 holdings, its largest position is Allspring Small Company Value Portfolio (100.0%) and the top 10 make up 100% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What to watch
- Concentrated: top 10 holdings are 100% of assets
- Front-end sales load up to 5.75%
- High turnover (209% a year) can mean more taxable distributions
Updated Nov 19, 2026
What SCVAX invests in
The Fund seeks long-term capital appreciation.
Under normal circumstances, we invest: at least 80% of the Funds net assets in equity securities of small-capitalization value companies (this strategy may only be changed upon 60 days prior notice to shareholders). To the extent the Fund uses derivatives, when such instruments provide investment exposure to the investments set forth in the first bullet above or exposure to one or more market risk factors associated with such investments, the Fund may include such derivatives in complying with the 80% requirement set out in this bullet. The Fund is a feeder fund that invests substantially all of its assets in the Small Company Value Portfolio, a master portfolio with a substantially identical investment objective and substantially similar investment strategies. We may invest in additional master portfolios, in other Allspring Funds, or directly in a portfolio of securities. We invest…
From the fund's prospectus (filed Aug 26, 2026).
SCVAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| SCVAX | −4.1% | +7.5% | +8.1% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What SCVAX costs
On a $10,000 investment, SCVAX's 1.15% expense ratio costs about $115 a year. The prospectus estimates $2,030 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
SCVAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Allspring Small Company Value Portfolio | 100.00% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 100% of the fund. See all top 25 holdings and asset mix →